Abstract
The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.
DOI
10.1192/bjp.2022.34
Publication Date
2022-08-22
Publication Title
British Journal of Psychiatry
Volume
221
Issue
2
First Page
488
Last Page
493
ISSN
0007-1250
Organisational Unit
Peninsula Medical School
Recommended Citation
Branford, D., & Shankar, R. (2022) 'Antidepressant prescribing for adult people with an intellectual disability living in England', British Journal of Psychiatry, 221(2), pp. 488-493. Available at: https://doi.org/10.1192/bjp.2022.34
